Rapid antimicrobial resistance detection for early directed therapies against infectious diseases

  25 September 2020

Targeting AMR has important clinical implications not only related to diagnosis and management but also prevention of infectious diseases, particularly those causing sepsis.

Determinants of deaths associated with antimicrobial-resistant pathogens known as causative agents of community and hospital-acquired bloodstream infections (BSIs) remain not fully explained. However, in a meta-analysis of sepsis treatment, the mortality rate in patients who were receiving inappropriate antibiotic therapy was higher than among patients who were appropriately treated.

Further reading: Global Cause
Author(s): Maurizio Sanguinetti
Effective Surveillance  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University

Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!